Abstract

The development of sequencing technology and the increase in biological data repositories have allowed for a more thorough understanding of the complex molecular aspects of diseases like cancer. This paper evaluates GediNET, an integrative machine learning approach that employs a Grouping-Scoring-Modeling (GSM) approach to classify different molecular subtypes of breast cancer using the BRCA LumAB_Her2Basal dataset against different feature selection approaches and machine learning classifiers. GediNET distinguishes itself from traditional feature selection methods by analyzing groups of genes to identify relevant disease-disease associations and potential biomarkers. The results of our study show that GediNET performs better than traditional approaches in terms of accuracy and Area Under the Curve (AUC) metrics. This demonstrates that GediNET is effective in understanding the genetic intricacies of breast cancer. This approach improves the identification of molecular subtypes and promotes the development of targeted medicines and customized medicine.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.